跳至主要内容
临床试验/NCT07175688
NCT07175688已完成不适用

Study of Metabolic Associated Fatty Liver Disease (MAFLD) and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients

Tanta University1 个研究点 分布在 1 个国家目标入组 217 人开始时间: 2022年4月10日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
217
试验地点
1
主要终点
Frequency of hepatic steatosis

研究概览

简要总结

This study aimed to evaluate the prevalence of metabolic associated fatty liver disease (MAFLD), fatty pancreas and hepatic fibrosis in obese and lean patients with chronic hepatitis B; either treatment naive or on treatment with first-line nucleos(t)ide analogs.

详细描述

Hepatitis B virus (HBV) infection is one of the major etiologies of chronic liver disease. Pathologies caused by HBV infection range from chronic hepatitis, fibrosis, cirrhosis, to hepatocellular carcinoma (HCC).

Obesity is another significant health burden. Abdominal obesity is a type of obesity that is commonly associated with severe metabolic disorders and cardiovascular diseases.

Previous research has linked abdominal obesity to non-alcoholic fatty liver disease (NAFLD), insulin resistance, type 2 diabetes mellitus (T2DM), and even metabolic syndrome. In 2020, NAFLD was renamed metabolic-associated fatty liver disease (MAFLD) by a group of experts. MAFLD is defined by the presence of liver steatosis in addition to overweight/obesity, type 2 diabetes mellitus (T2DM), or metabolic dysregulation with at least two risk factors, such as an increased waist circumference, pre-diabetes, hypertension, hypertriglyceridemia, and low serum high-density lipoprotein (HDL)-cholesterol levels.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older.
  • Both sexes.
  • Chronic hepatitis B patients.

排除标准

  • Hepatitis C virus (HCV) antibody positive.
  • Hepatocellular carcinoma (HCC).
  • Human immunodeficiency viruses (HIV).
  • Pregnancy.

结局指标

主要结局

Frequency of hepatic steatosis

时间窗: Immediately post-procedure (Up to 1 hour)

Frequency of hepatic steatosis (HS) were determined via transient elastography.

次要结局

  • Presence of pancreatic steatosis(Immediately post-procedure (Up to 1 hour))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samar Hosny Salama

Assistant lecturer of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

研究点 (1)

Loading locations...

相似试验